biotickrAdagio Therapeutics Inc
The ADGI stock trades on Nasdaq All Markets
Company Description
Adagio Therapeutics Inc is now in Invivyd. They developing antibodies to transcend the limits of naturally occurring immunity and provide higher levels of protection from viral diseases, beginning with COVID-19.
We are driven to change the paradigm for combatting viral infection by delivering rapid and lasting antibody immunity to protect the general public and ensure vulnerable populations are never left behind.
We are driven to change the paradigm for combatting viral infection by delivering rapid and lasting antibody immunity to protect the general public and ensure vulnerable populations are never left behind.
Drug Pipeline
Source: Adagio Therapeutics Inc - 20220924
Asset
Indication
Pre-Clinical
Ph1
Ph2
Ph3
Reg/Com
Phase
ADG20
COVID-19
Phase 1
COVID-19 Prevention
Phase 3
Pan-CoV
COVID-19 Vaccine
Preclinical
undisclosed
Influenza
Preclinical
0 Comments on ADGI stock
Newest
Conversation